🇺🇸 FDA
Patent

US 11679159

Compositions for transfecting resistant cell types

granted A61KA61K47/26A61K47/28

Quick answer

US patent 11679159 (Compositions for transfecting resistant cell types) held by Precision Nanosystems ULC expires Mon Jun 15 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Precision Nanosystems ULC
Grant date
Tue Jun 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 15 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K47/26, A61K47/28, A61K48/0008, A61K9/127